Ciprofloxacin-induced Q-T interval prolongation

American Journal of Health-System Pharmacy

Volumn 65, Issue 6, 2008, Pages 547-551

  Knorr, John P ^a   Moshfeghi, Mersedeh ^b   Sokoloski, Mary C ^b  

^a ALBERT EINSTEIN MEDICAL CENTER   (United States)

^b ST CHRISTOPHER'S HOSPITAL FOR CHILDREN   (United States)

Author keywords

Ciprofloxacin; Crohn disease; Long QT syndrome; Metronidazole; Pediatrics; Quinolones; Toxicity

Indexed keywords

AMPICILLIN; AZATHIOPRINE; AZTREONAM; CIPROFLOXACIN; FERROUS SULFATE; INFLIXIMAB; LANSOPRAZOLE; LINEZOLID; MESALAZINE; METHYLPREDNISOLONE; METRONIDAZOLE; PREDNISONE; PROBIOTIC AGENT; RANITIDINE; ACETAMIDE DERIVATIVE; ANTIINFECTIVE AGENT; OXAZOLIDINONE DERIVATIVE;

ADOLESCENT; ANTIMICROBIAL THERAPY; ARTHRALGIA; ARTICLE; BODY HEIGHT; BODY WEIGHT; CASE REPORT; CROHN DISEASE; DIARRHEA; DIZZINESS; HOSPITAL ADMISSION; HUMAN; LACTOBACILLUS; LONG QT SYNDROME; MALE; PHYSICAL EXAMINATION; PRIORITY JOURNAL; QT PROLONGATION; TREATMENT FAILURE; VITAL SIGN; WEIGHT REDUCTION; ABSCESS; BRADYCARDIA; CHEMICALLY INDUCED DISORDER; INTRAVENOUS DRUG ADMINISTRATION; RANDOMIZED CONTROLLED TRIAL;

ABSCESS; ACETAMIDES; ADOLESCENT; ANTI-INFECTIVE AGENTS; AZTREONAM; BRADYCARDIA; CIPROFLOXACIN; CROHN DISEASE; HUMANS; INFUSIONS, INTRAVENOUS; LONG QT SYNDROME; MALE; METRONIDAZOLE; OXAZOLIDINONES; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 41049088679     PISSN: 10792082     EISSN: None     Source Type: Journal    
DOI: 10.2146/ajhp070081     Document Type: Article

References (22)

1. Roden DM. Drug-induced prolongation of the QT interval. N Engl J Med. 2004; 350:1013-22.
2. Yap YG, Camm AJ. Drug induced QT prolongation and torsades de pointes. Heart. 2003; 89:1363-72.
3. Park MK, Troxler RG, eds. Pediatric cardiology for practitioners. 4th ed. St. Louis, MO: Mosby; 2002:34-51.
4. Al-Khatib SM, LaPointe NM, Kramer JM et al. What clinicians should know about the QT interval. JAMA. 2003; 289:2120-7.
5. Arizona Center for Education and Research on Therapeutics home page. www.torsades.org (accessed 2006 Oct 31).
6. Taketomo CK, Hodding JH, Kraus DM. Lexi-Comp's pediatric dosage handbook. 12th ed. Cleveland, OH: Lexi-Comp; 2005.
7. Sharieff GQ, Rao SO. The pediatric ECG. Emerg Med Clin North Am. 2006; 24:195-208.
8. Naranjo CA, Busto U, Sellers EM et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther. 1981; 30:239-45.
9. Owens RC Jr. QT prolongation with antimicrobial agents: understanding the significance. Drugs. 2004; 64:1091-124.
10. Makaryus AN, Byrns K, Makaryus MN et al. Effect of ciprofloxacin and levofloxacin on the QT interval: is this a significant "clinical" event? South Med J. 2006; 99:52-6.
11. Moss AJ. Drug-induced QT prolongation: an update. Ann Noninvasive Electrocardiol. 2006; 11:1-2.
12. Oliphant CM, Green GM. Quinolones: a comprehensive review. Am Fam Physician. 2002; 65:455-64.
13. Kang J, Wang L, Chen XL et al. Interactions of a series of fluoroquinolone antibacterial drugs with the human cardiac K+ channel HERG. Mol Pharmacol. 2001; 59:122-6.
14. Ball P. Quinolone-induced QT interval prolongation: a not-so-unexpected class effect. J Antimicrob Chemother. 2000; 45:557-9.
15. Katritsis D, Camm AJ. Quinolones: cardioprotective or cardiotoxic. Pacing Clin Electrophysiol. 2003; 26:2317-20.
16. Prabhakar M, Krahn AD. Ciprofloxacin-induced acquired long QT syndrome. Heart Rhythm. 2004; 1:624-6.
17. Flanagan MC, Mitchell ES, Haigney MCP. Ciprofloxacin-induced torsades de pointes. Int J Cardiol. 2006; 113:239-41.
18. Daya SK, Gowda RM, Khan IA. Ciprofloxacin- and hypocalcemia-induced torsades de pointes triggered by hemodialysis. Am J Ther. 2004; 11:77-9.
19. Letsas KP, Sideras A, Kounas SP et al. Drug-induced QT interval prolongation after ciprofloxacin administration in a patient receiving olanzapine. Int J Cardiol. 2006; 109:273-4.
20. Frothingham R. Rates of torsades de pointes associated with ciprofloxacin, ofloxacin, levofloxacin, gatifloxacin, and moxifloxacin. Pharmacotherapy. 2001; 21:1468-72.
21. Noel GJ, Natarajan J, Chien S et al. Effects of three fluoroquinolones on QT interval in healthy adults after single doses. Clin Pharmacol Ther. 2003; 73:292-303.
22. Tsikouris JP, Peeters MJ, Cox CD et al. Effects of three fluoroquinolones on QT analysis after standard treatment courses. Ann Noninvasive Electrocardiol. 2006; 11:52-6.